Caltech Researcher Unveils Low-Cost Device That Detects SARS-CoV-2 Virus, Anti-Virus Antibodies, and Inflammatory Molecules in Under 10 Minutes; Device Designed for Home Use & Detects Virus in Infected, But Still Pre-Symptomatic Individuals

One feature of the COVID-19 virus that makes it so difficult to contain is that it can be easily spread to others by a person who has yet to show any signs of infection. The carrier of the virus might feel perfectly well and go about his/her daily business--taking the virus with him/her to work, to the home of a family member, or to public gatherings. A crucial part of the global effort to stem the spread of the pandemic, therefore, is the development of tests that can rapidly identify infections in people who are not yet symptomatic. Now, Caltech researchers have developed a new type of multiplexed test (a test that combines multiple kinds of data) with a low-cost sensor that may enable the at-home diagnosis of a COVID infection through rapid analysis of small volumes of saliva or blood, without the involvement of a medical professional, in less than 10 minutes. The research was conducted in the lab of Wei Gao, PhD, Assistant Professor in the Andrew and Peggy Cherng Department of Medical Engineering at Caltech. Previously, Dr. Gao and his team have previously developed wireless sensors that can monitor conditions such as gout, as well as stress levels, through the detection of extremely low levels of specific compounds in blood, saliva, or sweat. Dr. Gao's sensors are made of graphene, a sheet-like form of carbon. A plastic sheet etched with a laser generates a 3D graphene structure with tiny pores. Those pores create a large amount of surface area on the sensor, which makes it sensitive enough to detect, with high accuracy, compounds that are only present in very small amounts. In this sensor, the graphene structures are coupled with antibodies, immune system molecules that are sensitive to specific proteins, like those on the surface of a COVID virus, for example.
Login Or Register To Read Full Story